help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riis, A. L. D.
Right arrow Articles by Jørgensen, J. O. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riis, A. L. D.
Right arrow Articles by Jørgensen, J. O. L.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 2 853-857
Copyright © 2003 by The Endocrine Society

Hyperthyroidism Is Associated with Suppressed Circulating Ghrelin Levels

Anne Lene Dalkjær Riis, Troels Krarup Hansen, Niels Møller, Jørgen Weeke and Jens Otto Lunde Jørgensen

Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital (A.L.D.R., T.K.H., J.W., J.O.L.J.), and Institute of Experimental Clinical Research (N.M.), Aarhus University, 8000 Aarhus, Denmark

Address all correspondence and requests for reprints to: Dr. Anne Lene Riis, Medical Department M, Aarhus University Hospital, 8000 Arhus, Denmark. E-mail: anne.lene.riis{at}iekf.au.dk.

Ghrelin stimulates GH secretion as well as appetite and food intake. To explore whether ghrelin is involved in the regulation of appetite and body weight in hyperthyroidism, circulating ghrelin levels were measured in nine hyperthyroid patients before and after medical treatment and compared with those in eight healthy control subjects. All participants were studied in the postabsorptive state and during a 3-h euglycemic hyperinsulinemic clamp. Before treatment the patients had 3- to 5-fold elevations of T3, and during treatment the patients gained 5 kg of body weight. Ghrelin levels were decreased in hyperthyroidism both in the fasting state (hyperthyroid, 1080 ± 195 pg/ml; euthyroid, 1480 ± 215 pg/ml; P = 0.03) and during clamp (hyperthyroid, 833 ± 150 pg/ml; euthyroid, 1210 ± 180 pg/m; P = 0.02). After treatment, ghrelin levels did not differ from those in control subjects. In all three study groups the clamp significantly reduced ghrelin levels compared with fasting levels. In conclusion, ghrelin levels are reduced in hyperthyroidism and become normalized by medical antithyroid treatment. Hyperinsulinemia suppresses ghrelin regardless of thyroid status. Ghrelin is not a primary stimulator of appetite and food intake in hyperthyroidism, and the mechanisms underlying the suppressive effect of hyperthyroidism on ghrelin secretion remain unclear.

This work was supported by grants from The Danish Health Research Council (Grant 9600822; Aarhus University-Novo Nordisk Center for Research in Growth and Regeneration), the World Anti Doping Agency, the Aarhus University Research Fund, and The Musikforlæggerne Agnes and Knut Mørks Fund.

Abbreviations: EE, Energy expenditure; FFA, free fatty acids; LBM, lean body mass; RQ, respiratory quotient.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. L. D. Riis, J. O. L. Jorgensen, P. Ivarsen, J. Frystyk, J. Weeke, and N. Moller
Increased Protein Turnover and Proteolysis Is an Early and Primary Feature of Short-Term Experimental Hyperthyroidism in Healthy Women
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3999 - 4005.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Gjedde, E. T. Vestergaard, L. C. Gormsen, A. L. D. Riis, J. Rungby, N. Moller, J. Weeke, and J. O. L. Jorgensen
Serum Ghrelin Levels Are Increased in Hypothyroid Patients and Become Normalized by L-Thyroxine Treatment
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2277 - 2280.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. H. St-Pierre, A. D. Karelis, L. Coderre, F. Malita, J. Fontaine, D. Mignault, M. Brochu, J.-P. Bastard, K. Cianflone, E. Doucet, et al.
Association of Acylated and Nonacylated Ghrelin with Insulin Sensitivity in Overweight and Obese Postmenopausal Women
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 264 - 269.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
L. C Gormsen, J. Gjedsted, S. Gjedde, E. T. Vestergaard, J. S Christiansen, J. O. Jorgensen, S. Nielsen, and N. Moller
Free fatty acids decrease circulating ghrelin concentrations in humans.
Eur. J. Endocrinol., May 1, 2006; 154(5): 667 - 673.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
N. A. Tritos and E. G. Kokkotou
The Physiology and Potential Clinical Applications of Ghrelin, a Novel Peptide Hormone
Mayo Clin. Proc., May 1, 2006; 81(5): 653 - 660.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Langenberg, J. Bergstrom, G. A. Laughlin, and E. Barrett-Connor
Ghrelin and the Metabolic Syndrome in Older Adults
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6448 - 6453.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
O. Gimenez-Palop, G. Gimenez-Perez, D. Mauricio, E. Berlanga, N. Potau, C. Vilardell, J. Arroyo, J.-M. Gonzalez-Clemente, and A. Caixas
Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes
Eur. J. Endocrinol., July 1, 2005; 153(1): 73 - 79.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Nishi, H. Hiejima, H. Mifune, T. Sato, K. Kangawa, and M. Kojima
Developmental Changes in the Pattern of Ghrelin's Acyl Modification and the Levels of Acyl-Modified Ghrelins in Murine Stomach
Endocrinology, June 1, 2005; 146(6): 2709 - 2715.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. H. St-Pierre, A. D. Karelis, K. Cianflone, F. Conus, D. Mignault, R. Rabasa-Lhoret, M. St-Onge, A. Tremblay-Lebeau, and E. T. Poehlman
Relationship between Ghrelin and Energy Expenditure in Healthy Young Women
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5993 - 5997.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Y. Jeon, S. Lee, H. H. Kim, Y. J. Kim, H. C. Son, D. H. Kim, and M. S. Sim
Changes in Plasma Ghrelin Concentration Immediately after Gastrectomy in Patients with Early Gastric Cancer
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5392 - 5396.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. J. van der Lely, M. Tschop, M. L. Heiman, and E. Ghigo
Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
Endocr. Rev., June 1, 2004; 25(3): 426 - 457.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Erdmann, R. Topsch, F. Lippl, P. Gussmann, and V. Schusdziarra
Postprandial Response of Plasma Ghrelin Levels to Various Test Meals in Relation to Food Intake, Plasma Insulin, and Glucose
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 3048 - 3054.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Murdolo, P. Lucidi, C. Di Loreto, N. Parlanti, A. De Cicco, C. Fatone, C. G. Fanelli, G. B. Bolli, F. Santeusanio, and P. De Feo
Insulin is Required for Prandial Ghrelin Suppression in Humans
Diabetes, December 1, 2003; 52(12): 2923 - 2927.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Hataya, T. Akamizu, H. Hosoda, N. Kanamoto, K. Moriyama, K. Kangawa, K. Takaya, and K. Nakao
Alterations of Plasma Ghrelin Levels in Rats with Lipopolysaccharide-Induced Wasting Syndrome and Effects of Ghrelin Treatment on the Syndrome
Endocrinology, December 1, 2003; 144(12): 5365 - 5371.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. E. Caminos, R. Nogueiras, M. Blanco, L. M. Seoane, S. Bravo, C. V. Alvarez, T. Garcia-Caballero, F. F. Casanueva, and C. Dieguez
Cellular Distribution and Regulation of Ghrelin Messenger Ribonucleic Acid in the Rat Pituitary Gland
Endocrinology, November 1, 2003; 144(11): 5089 - 5097.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society